August 25, 2026 02:36 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Reservation for poor, not caste’: Stir at Delhi’s Jantar Mantar | Dalit woman 'gangrape-murder' shocker in Karnataka: 4 arrested after body found in well | India dismisses Pakistan's 'frustration' over US envoy's J&K remark | Centre denies US visit clearance to Telangana CM Revanth Reddy, says programmes 'not appropriate' | Delhi Police register FIR in pellet gun case after Rahul Gandhi's sit-in | Rahul Gandhi stages dharna at Delhi police station over CJP protest crackdown, targets Amit Shah | CJP school tour turns chaotic in Jaipur: Cars vandalised, stones pelted as Ashutosh Ranka alleges BJP ‘goons’ attack | Vande Mataram row: Kangana Ranaut slams Sharmila Tagore, says ‘come out of Hindu-Muslim mindset’ | Jadavpur erupts again: ABVP-SFI clash, police barricades shattered as fresh tension grips area | Ex-Congress MP and 1984 anti-Sikh riots convict Sajjan Kumar dies while serving life sentence
Cervical Cancer Vax
Image Credit: Wallpaper Cave

India's first indigenously developed cervical cancer vaccine launched

| @indiablooms | Sep 02, 2022, at 06:47 am

The Serum Institute of India (SII) and the Department of Biotechnology (DBT) Thursday officially announced India's first indigenous vaccine for cervical cancer.

Union Minister of Science and Technology Jitendra Singh along with SII CEO Adar Poonawalla launched the vaccine at IIC Delhi.

Drugs Controller General of India (DCGI) granted market authorisation for the jibe in July.

As many as 42 lakh women have died due to this disease in India since 2019, according to World Health Organisation (WHO) data. It is the second most frequent cancer among women in the age group between 15 to 44.

The HPV vaccine protects against the types of HPV that most often cause cervical, vaginal, and vulvar cancers.

The vaccine may be priced between Rs 200-400 but it's not finalised yet, SII CEO, Adar Poonawalla said. The company plans to manufacture 200 million doses in 2 years.

The government may launch the vaccine under the National Immunisation programme for 9-14-year-old girls in the next few months.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.